ICU Medical Inc (OQ:ICUI)

Business Focus: Medical Equipment, Supplies & Distribution

Jun 16, 2020 04:18 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICU Medical, Inc. - ICUI
Pomerantz LLP is investigating claims on behalf of investors of  ICU Medical, Inc. (“ICU Medical” or the “Company”) (NASDAQ: ICUI).   Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 7980....
Jun 10, 2020 01:21 pm ET
ICU Medical Investors: Company Investigated by the Portnoy Law Firm, CEO sold $3.06 million of shares, according to a filing with the U.S. Securities & Exchange Commission
The Portnoy Law Firm advises ICU Medical, Inc. (NASDAQ: ICUI) investors that the firm has initiated an investigation into alleged violations of securities laws, and may file a lawsuit on behalf of investors. Investors are encouraged to contact...
Jun 08, 2020 05:56 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICU Medical, Inc. - ICUI
Pomerantz LLP is investigating claims on behalf of investors of ICU Medical, Inc. (“ICU Medical” or the “Company”) (NASDAQ: ICUI). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 7980....
Jun 05, 2020 08:44 am ET
ICU Medical Investors: Company Investigated by the Portnoy Law Firm
The Portnoy Law Firm advises ICU Medical, Inc. (NASDAQ: ICUI) investors that the firm has initiated an investigation into alleged violations of securities laws, and may file a lawsuit on behalf of investors. Investors are encouraged to contact...
Jun 03, 2020 04:21 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICU Medical, Inc. - ICUI
Pomerantz LLP is investigating claims on behalf of investors of ICU Medical, Inc. (“ICU Medical” or the “Company”) (NASDAQ: ICUI). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 7980....
Jun 02, 2020 03:05 pm ET
ICUI Investor Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of ICU Medical, Inc. and Encourages Investors to Contact the Firm
NEW YORK, June 2, 2020 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ICU Medical, Inc. ("ICU" or "the Company") (NASDAQ: ICUI). Investors who purchased ICU securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/icui.              ...
May 28, 2020 04:53 pm ET
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against ICU Medical, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ICU Medical, Inc. (“ICU Medical” or “the Company”) (NASDAQ:
May 28, 2020 03:58 pm ET
ICU MEDICAL INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In ICU Medical, Inc. To Contact The Firm
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against ICU Medical, Inc. (“ICU Medical” or the “Company”) (NASDAQ:ICUI). If you invested in ICU Medical stock or options and would like to discuss...
May 27, 2020 07:25 pm ET
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against ICU Medical, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ICU Medical, Inc. (“ICU Medical” or “the Company”) (NASDAQ:
May 27, 2020 06:30 pm ET
EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against ICU Medical, Inc. – ICUI
Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of ICU Medical, Inc. (NASDAQ: ICUI) resulting from allegations that ICU Medical may have issued materially misleading business information to the investing public.
May 27, 2020 08:18 am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICU Medical, Inc. - ICUI
Pomerantz LLP is investigating claims on behalf of investors of  ICU Medical, Inc. (“ICU Medical” or the “Company”) (NASDAQ: ICUI).   Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 7980....
May 22, 2020 06:24 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICU Medical, Inc. - ICUI
Pomerantz LLP is investigating claims on behalf of investors of  ICU Medical, Inc. (“ICU Medical” or the “Company”) (NASDAQ: ICUI).   Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 7980....
May 21, 2020 04:20 pm ET
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of ICU Medical, Inc. (ICUI) on Behalf of Investors
Law Offices of Howard G. Smith continues its investigation on behalf of ICU Medical, Inc. (“ICU” or the “Company”) (NASDAQ: ICUI) investors concerning the Company and its officers’ possible violations of federal securities laws.
May 20, 2020 01:19 pm ET
ICU Medical, Inc. Investors: Company Investigated by the Portnoy Law Firm
The Portnoy Law Firm advises ICU Medical, Inc. (NASDAQ: ICUI) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors. Investors are encouraged to contact attorney...
May 19, 2020 07:00 pm ET
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of ICU Medical, Inc. (ICUI) on Behalf of Investors
Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of ICU Medical, Inc. (“ICU” or the “Company”) (NASDAQ:
May 19, 2020 05:00 pm ET
The Law Offices of Frank R. Cruz Announces Investigation on Behalf of ICU Medical, Inc. Investors (ICUI)
The Law Offices of Frank R. Cruz announces an investigation on behalf of ICU Medical, Inc. (“ICU” or the “Company”) (NASDAQ:
May 19, 2020 02:54 pm ET
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of ICU Medical, Inc. (ICUI) on Behalf of Investors
Law Offices of Howard G. Smith announces an investigation on behalf of ICU Medical, Inc. (“ICU” or the “Company”) (NASDAQ: ICUI) investors concerning the Company and its officers’ possible violations of federal securities laws.
May 15, 2020 03:49 pm ET
ICU Medical, Inc. Investors: Company Investigated by the Portnoy Law Firm
The Portnoy Law Firm advises ICU Medical, Inc. (NASDAQ: ICUI) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors. Investors are encouraged to contact attorney...
May 15, 2020 11:42 am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICU Medical, Inc. - ICUI
Pomerantz LLP is investigating claims on behalf of investors of ICU Medical, Inc. (“ICU Medical” or the “Company”) (NASDAQ: ICUI). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 7980....
May 08, 2020 12:17 pm ET
ICU Medical Issues a Voluntary Nationwide Recall of Lactated Ringer's Injection, USP Due to the Presence of Particulate Matter
LAKE FOREST, Ill., May 8, 2020 /PRNewswire/ -- ICU Medical, Inc. is voluntarily recalling one single lot of Lactated Ringer's Injection, USP. The products are being recalled to the hospital/user level due to the presence of particulate matter identified as iron oxide.  ICU Medical became aware of this issue through a single customer complaint.  ...
May 07, 2020 04:05 pm ET
ICU Medical, Inc. Announces First Quarter 2020 Results and Updates Fiscal Year 2020 Guidance
ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced financial results for the quarter ended March 31, 2020....
Apr 20, 2020 07:30 am ET
ICU Medical, Inc. Announces Time of First Quarter 2020 Earnings Conference Call
ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced the time of its first quarter 2020 earnings release and...
Feb 28, 2020 11:45 am ET
ICU Medical, Inc. to Present at the Raymond James 41st Annual Institutional Investors Conference
ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced that Company management will present at the Raymond James...
Feb 27, 2020 04:05 pm ET
ICU Medical, Inc. Announces Fourth Quarter 2019 Results
ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced financial results for the quarter ended December 31, 2019....
Feb 06, 2020 07:30 am ET
ICU Medical, Inc. Announces Time of Fourth Quarter and Fiscal Year 2019 Earnings Conference Call
ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced the time of its fourth quarter and fiscal year 2019 earnings...
Jan 07, 2020 04:05 pm ET
ICU Medical, Inc. to Present at the J.P. Morgan 38th Annual Healthcare Conference
ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced that Company management will present at the J.P. Morgan 38th...
Nov 11, 2019 04:05 pm ET
ICU Medical, Inc. Announces Third Quarter 2019 Results
ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced financial results for the quarter ended September 30, 2019....
Nov 04, 2019 06:00 am ET
ICU Medical, Inc. to Acquire Pursuit Vascular, Inc.
SAN CLEMENTE, Calif., Nov. 4, 2019 /PRNewswire/ -- ICU Medical, Inc. (NASDAQ:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, announced today that it has entered into a definitive agreement to acquire Pursuit Vascular, Inc. for $75M with an additional earnout payment potentially due in 2021. Pursuit Vascular is a privately-held medical device company with a primary focus on innovative catheter disinfecting products and technologies to reduce costly bloodstream infections and lower healthcare costs...
Oct 30, 2019 02:00 pm ET
ICU Medical, Inc. Issues a Voluntary Nationwide Recall of Lactated Ringer's Injection, USP and 0.9% Sodium Chloride Injection, USP Due to Presence of Particulate Matter
LAKE FOREST, Ill., Oct. 30, 2019 /PRNewswire/ -- ICU Medical, Inc. (Nasdaq: ICUI) is voluntarily recalling one single lot of Lactated Ringer's Injection, USP, and one single lot of 0.9% Sodium Chloride Injection, USP. The products are being recalled to the hospital level due to the presence of particulate matter. ...
Oct 22, 2019 07:30 am ET
ICU Medical, Inc. Announces Time of Third Quarter 2019 Earnings Conference Call
ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced the time of its third quarter 2019 earnings release and...
Oct 07, 2019 04:15 pm ET
ICU Medical Issues a Voluntary Nationwide Recall of Certain Lots of Plum and Sapphire Microbore Infusion Sets with Inline Filters
SAN CLEMENTE, Calif., Oct. 7, 2019 /PRNewswire/ -- ICU Medical, Inc. (Nasdaq: ICUI) announced a voluntary recall on 29 July 2019 of certain lots of Plum and Sapphire Microbore Infusion Sets with inline filters due to the potential for small amounts of fluid leaking out of the air vents on the inline filters. To date, ICU Medical is not aware of adverse events related to this matter and is issuing this notification out of an abundance of caution....
Sep 09, 2019 07:00 am ET
ICU Medical, Inc. to Present at the 17th Annual Morgan Stanley Global Healthcare Conference
ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced that Company management will present at the Morgan Stanley...
Aug 07, 2019 04:02 pm ET
ICU Medical, Inc. Announces Second Quarter 2019 Results
ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced financial results for the quarter ended June 30, 2019....
Jul 17, 2019 07:30 am ET
ICU Medical, Inc. Announces Time of Second Quarter 2019 Earnings Conference Call
ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced the time of its second quarter 2019 earnings release and...
Jul 08, 2019 05:00 pm ET
ICU Medical CFO Announces Intention to Retire from CFO Role After Close of FY19
ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care applications, today announced that Scott E. Lamb, its Chief Financial Officer and Treasurer,...
May 09, 2019 04:05 pm ET
ICU Medical, Inc. Announces First Quarter 2019 Results
ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced financial results for the quarter ended March 31, 2019....
Apr 18, 2019 07:30 am ET
ICU Medical, Inc. Announces Time of First Quarter 2019 Earnings Conference Call
ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced the time of its first quarter 2019 earnings release and...
Mar 01, 2019 02:10 pm ET
ICU Medical, Inc. to Present at the Raymond James 40th Annual Institutional Investors Conference
ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care applications, today announced that Company management will present at the Raymond James 40th...
Feb 28, 2019 04:05 pm ET
ICU Medical, Inc. Announces Fourth Quarter 2018 Results
ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care applications, today announced financial results for the quarter ended December 31, 2018....
Feb 11, 2019 07:20 am ET
Recent Analysis Shows Corcept Therapeutics, CDK Global, Dynavax Technologies, ICU Medical, American Vanguard, and Cabot Market Influences — Renewed Outlook, Key Drivers of Growth
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Corcept Therapeutics Incorporated (NASDAQ:CORT), CDK Global, Inc....
Feb 07, 2019 07:30 am ET
ICU Medical, Inc. Announces Time of Fourth Quarter and Fiscal Year 2018 Earnings Conference Call
ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced the time of its fourth quarter and fiscal year 2018 earnings...
Dec 27, 2018 08:00 am ET
ICU Medical, Inc. to Present at the 37th J.P. Morgan Healthcare Conference
ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced that Company management will present at the 37th J.P. Morgan...
Nov 08, 2018 04:05 pm ET
ICU Medical, Inc. Announces Third Quarter 2018 Results
ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced financial results for the quarter ended September 30, 2018....
Oct 23, 2018 07:55 am ET
Report: Exploring Fundamental Drivers Behind Helen of Troy, BioPharmX, Fair Isaac, Frontier Communications, ICU Medical, and Darling Ingredients — New Horizons, Emerging Trends, and Upcoming Developme
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Helen of Troy Limited (NASDAQ:HELE), BioPharmX Corporation (NYSE:BPMX),...
Oct 22, 2018 07:00 am ET
ICU Medical, Inc. Announces Time of Third Quarter 2018 Earnings Conference Call
ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced the time of its third quarter 2018 earnings release and...
Oct 10, 2018 10:00 am ET
Imprivata Enters into Agreement with ICU Medical to Improve Security for Infusion Pumps
Imprivata®, the healthcare IT security company, today announced a new collaboration with ICU Medical Inc., a leader in the development, manufacture, and sale of innovative medical products used in infusion therapy and critical care applications, to...
Sep 10, 2018 05:21 pm ET
ICU Medical, Inc. to Present at the 2018 Morgan Stanley Global Healthcare Conference
ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced that Company management will present at the 2018 Morgan...
Aug 09, 2018 04:01 pm ET
ICU Medical, Inc. Announces Second Quarter 2018 Results
ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced financial results for the quarter ended June 30, 2018....
Jul 27, 2018 08:00 am ET
New Research: Key Drivers of Growth for ICU Medical, A. Schulman, Verso, Eli Lilly, Spectrum Pharmaceuticals, and Intuit — Factors of Influence, Major Initiatives and Sustained Production
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ICU Medical, Inc. (NASDAQ:ICUI), A. Schulman, Inc. (NASDAQ:SHLM), Verso...
Jul 17, 2018 04:05 pm ET
ICU Medical, Inc. Announces Time of Second Quarter 2018 Earnings Conference Call
ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced the time of its second quarter 2018 earnings release and...
Jun 19, 2018 08:00 am ET
ICU Medical's Plum 360 Infusion System is the First Medical Device to Earn UL Cybersecurity Assurance Program (UL CAP) Certification
SAN CLEMENTE, Calif., June 19, 2018 /PRNewswire/ -- ICU Medical, Inc., a worldwide leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care applications, has become the first medical device manufacturer to obtain certification under the UL Cybersecurity Assurance Program (UL CAP), a new cybersecurity management program from UL designed to minimize risks by creating standardized, testable criteria for assessing software vulnerabilities and weaknesses to help reduce exploitation, address known malware, enhance security controls an...
May 22, 2018 08:20 am ET
New Research: Key Drivers of Growth for EPAM, Jernigan Capital, Holly Energy Partners, ICU Medical, San Juan Basin Royalty Trust, and Equity Residential — Factors of Influence, Major Initiatives and S
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of EPAM Systems, Inc. (NYSE:EPAM), Jernigan Capital, Inc. (NYSE:JCAP), Holly...
May 09, 2018 04:05 pm ET
ICU Medical, Inc. Announces First Quarter 2018 Results
ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care applications, today announced financial results for the quarter ended March 31, 2018. First...
Apr 12, 2018 04:05 pm ET
ICU Medical, Inc. Announces Time of First Quarter 2018 Earnings Conference Call
SAN CLEMENTE, Calif., April 12, 2018 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care applications, today announced the time of...
Mar 28, 2018 08:25 am ET
Recent Analysis Shows ICU Medical, Motorcar Parts of America, Protagonist Therapeutics, A. Schulman, PennantPark Investment, and H&E Equipment Services Market Influences — Renewed Outlook, Key Drivers
NEW YORK, March 28, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ICU Medical, Inc. (NASDAQ:ICUI), Motorcar Parts...
Mar 09, 2018 04:54 pm ET
Take-Two Interactive Software, SVB Financial and Nektar Pharmaceuticals Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
NEW YORK, March 9, 2018 /PRNewswire/ -- S&P Dow Jones Indices will make the following index adjustments to the S&P 500, S&P MidCap 400 and S&P SmallCap 600 to ensure each index more appropriately represents its market capitalization range. The changes will be effective prior to the open on Monday, March 19 to coincide with the March rebalance. All companies moving to the S&P 500 have total market capitalizations above $12 billion. All companies moving to the S&P MidCap 400 and S&P SmallCap 600 are more appropriate for those indices....
Mar 02, 2018 12:51 pm ET
ICU Medical, Inc. to Present at Raymond James’ 39th Annual Institutional Investors Conference
SAN CLEMENTE, Calif., March 02, 2018 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care applications, today announced that Company management...
Mar 01, 2018 04:05 pm ET
Feb 05, 2018 07:30 am ET
ICU Medical, Inc. Announces Time of Fourth Quarter and Fiscal Year 2017 Earnings Conference Call
SAN CLEMENTE, Calif., Feb. 05, 2018 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care applications, today announced the time of...
Jan 25, 2018 07:50 am ET
New Research: Key Drivers of Growth for Hub Group, Meridian, ICU Medical, First Merchants, AAC, and Covenant Transportation Group — Factors of Influence, Major Initiatives and Sustained Production
NEW YORK, Jan. 25, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Hub Group, Inc. (NASDAQ:HUBG), Meridian Bancorp,...
Dec 18, 2017 07:30 am ET
ICU Medical, Inc. to Present at the 36th Annual J.P. Morgan Healthcare Conference
SAN CLEMENTE, Calif., Dec. 18, 2017 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care applications, today announced that Company management...
Nov 09, 2017 04:05 pm ET
ICU Medical, Inc. Announces Third Quarter 2017 Results
Company Updates FY 2017 Guidance and Provides Initial FY 2018 EBITDA and Adjusted EPS Guidance
Oct 12, 2017 04:05 pm ET
ICU Medical, Inc. Announces Time of Third Quarter 2017 Earnings Call
SAN CLEMENTE, Calif., Oct. 12, 2017 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care applications, today announced the time of its third quarter 2017 earnings release and conference call....
Aug 09, 2017 04:05 pm ET
ICU Medical, Inc. Announces Second Quarter 2017 Results
SAN CLEMENTE, Calif., Aug. 09, 2017 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care applications, today announced financial results for the quarter ended June 30, 2017....
Jul 28, 2017 05:30 pm ET
ICU Medical Issues a Voluntary Nationwide Recall of One Lot of 0.9% Sodium Chloride Injection Due to the Presence of Particulate Matter
LAKE FOREST, Ill., July 28, 2017 /PRNewswire/ -- ICU Medical, Inc. is voluntarily recalling one lot of 0.9% Sodium Chloride Injection, USP 1000 mL to the hospital/user level due to a confirmed customer complaint of particulate matter identified as stainless steel within a single flexible container....
Jul 11, 2017 07:30 am ET
ICU Medical, Inc. Announces Time of Second Quarter 2017 Earnings Call
SAN CLEMENTE, Calif., July 11, 2017 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care applications, today announced the time of its second quarter 2017 earnings release and conference call....
May 10, 2017 04:05 pm ET
ICU Medical, Inc. Announces First Quarter 2017 Results
SAN CLEMENTE, Calif., May 10, 2017 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care applications, today announced financial results for the quarter ended March 31, 2017....
Apr 20, 2017 11:00 am ET
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of ICU Medical, Inc. (ICUI)
NEW YORK, April 20, 2017 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ICE Medical, Inc. ("ICU Medical" or the "Company") (NASDAQ: ICUI). Such investors are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/icui. ...
Apr 19, 2017 02:06 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICU Medical, Inc. -- ICUI
NEW YORK, April 19, 2017 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  ICU Medical, Inc. ("ICU Medical" or the "Company") (NASDAQ: ICUI).   Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980....
Feb 15, 2017 08:00 am ET
Integrating ICU Medical Infusion Devices with Hospital Electronic Medical Records Decreased Major Dosing Errors by 52 Percent
SAN CLEMENTE, Calif., Feb. 15, 2017 /PRNewswire/ -- ICU Medical, Inc. (NASDAQ: ICUI), a leader in innovative medical devices for infusion therapy, oncology and critical care, today announced results of a new multi-hospital study that shows dramatic improvements in potentially catastrophic dosing errors (PCDE) and drug library compliance when its Plum® infusion pumps and Hospira MedNet® safety software are integrated with hospitals' electronic medical records (EMR). Results of the study will be featured in the company's booth #1053 at the HIMSS '17 Conference and Exhibition February 19-23 in ...
Jan 05, 2017 04:05 pm ET
ICU Medical, Inc. Provides Update on Hospira Infusion Systems Transaction
U.S. and Other Required Antitrust Clearances for Transaction ReceivedCompany Expects Deal to Close in February 2017 Terms of the Deal Modified for Value-Creating and Risk Mitigated StructureICU Medical Inc. Management Conference Call Tomorrow, January 6th, at 8:30 am EST, Details Below SAN CLEMENTE, Calif., Jan. 05, 2017 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (NASDAQ:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy, oncology and critical care applications, today announced that ICU Medical and Pfizer Inc. (NYSE:PFE) have modifie...
Dec 01, 2016 08:00 am ET
ICU Medical Launches the All-New Diana™ Compounding Workflow System at the American Society of Health-System Pharmacists (ASHP) Midyear Meeting in Las Vegas
SAN CLEMENTE, Calif., Dec. 1, 2016 /PRNewswire/ -- ICU Medical, Inc. (NASDAQ: ICUI) today announced the launch of the all-new Diana™ compounding workflow system at the American Society of Health-System Pharmacists (ASHP) Midyear Meeting and Exhibition in Las Vegas December 5-7, 2016. Diana is the first and only system to combine automated compounding and IV workflow technologies with wireless pharmacist notification. The Diana system allows hospital pharmacists to remotely verify the accuracy of each patient preparation on a handheld tablet display without having to gown up and enter the cle...
Nov 09, 2016 04:05 pm ET
ICU Medical, Inc. Announces Third Quarter 2016 Results
SAN CLEMENTE, Calif., Nov. 09, 2016 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy, oncology and critical care applications, today announced financial results for the third quarter ended September 30, 2016....
Oct 17, 2016 04:05 pm ET
ICU Medical, Inc. Announces Time of Third Quarter 2016 Earnings Call
SAN CLEMENTE, Calif., Oct. 17, 2016 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy, oncology and critical care applications, today announced the time of its third quarter 2016 earnings release and conference call....
Aug 08, 2016 04:05 pm ET
ICU Medical, Inc. Announces Second Quarter 2016 Results
SAN CLEMENTE, Calif., Aug. 08, 2016 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy, oncology and critical care applications, today announced financial results for the second quarter ended June 30, 2016....
Jul 18, 2016 03:05 pm ET
ICU Medical, Inc. Announces Time of Second Quarter 2016 Earnings Call
SAN CLEMENTE, Calif., July 18, 2016 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy, oncology and critical care applications, today announced the time of its second quarter 2016 earnings release and conference call....
May 10, 2016 04:05 pm ET
ICU Medical, Inc. Announces First Quarter 2016 Results
SAN CLEMENTE, Calif., May 10, 2016 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy, oncology and critical care applications, today announced financial results for the first quarter ended March 31, 2016....
Mar 21, 2016 09:00 am ET
B. Braun and ICU Medical Sign Expanded Long-Term International Distribution Agreement
SAN CLEMENTE, Calif., March 21, 2016 /PRNewswire/ -- ICU Medical Inc. (NASDAQ: ICUI) today announced that it has entered into a long-term distribution agreement with B. Braun Melsungen AG, giving B. Braun distribution rights to promote ICU Medical's SwabCap® disinfecting cap for needlefree connectors in selected countries outside the United States. Under the expanded agreement, customers will be able to purchase the SwabCap family of products from B. Braun in more than 30 countries around the world....